Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Observational 1

Sponsor

Cancer Type

CNS 1

Conditions

Neuroblastoma 51Central Nervous System Neoplasms 43Medulloblastoma 22Brain Neoplasms 20Astrocytoma 15Oligodendroglioma 14Rhabdoid Tumor 7Choroid Plexus Neoplasms 7Neoplasms 6Glioma 6Optic Nerve Glioma 5Ganglioneuroblastoma 5Spinal Cord Neoplasms 4Sarcoma 4Neuroectodermal Tumors, Primitive 4Glioblastoma 4Sarcoma, Ewing 3Rhabdomyosarcoma 3Recurrence 3Lymphoma 3Gliosarcoma 3Ependymoma 3Wilms Tumor 2Pinealoma 2Neurofibromatosis 1 2Familial ependymoma 2Untreated Childhood Medulloblastoma 1Retinoblastoma 1Pyloric Stenosis, Hypertrophic 1Ototoxicity 1

Interventions

sodium thiosulfate 1Vincristine 1Restraint, Physical 1Radiosurgery 1Methotrexate 1Mental Status and Dementia Tests 1Magnetic Resonance Spectroscopy 1Cyclophosphamide 1Cisplatin 1Chemotherapy, Adjuvant 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Ototoxicity × Vincristine × CNS × Clear all
NCT00683319 2013-09-20

Observing Young Patients With Ependymoma Undergoing Standard Combination Chemotherapy

National Cancer Institute (NCI)

Active not recruiting
50 enrolled
CNS

Ototoxicity, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡